Evidence map›Paper›PMID 40395395›Full record

ArticleJournal of clinical and translational science2025

Advancing research translation in addiction and pain: A portfolio analysis of the NIH HEAL initiative.

Ginnie Sawyer-Morris, Merve Ulukaya, Bryce Kushmerick-McCune, Kendra J Clark, Jacqueline Bruce, Scott Gatzke, Scott T Walters, Faye S Taxman

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ginnie Sawyer-MorrisFriends Research Institute, Baltimore, MD, USA.ORCID https://orcid.org/0000-0001-7821-6440
Merve UlukayaGeorge Mason University, Schar School of Policy and Government, Fairfax, VA, USA.
Bryce Kushmerick-McCuneSam Houston State University Department of Criminal Justice and Criminology, Huntsville, TX, USA.
Kendra J ClarkGeorge Mason University, Schar School of Policy and Government, Fairfax, VA, USA.
Jacqueline BruceOregon Social Learning Center, Eugene, OR, USA.
Scott GatzkeUniversity of Wisconsin Center for Health Enhancement Systems Studies, Madison, WI, USA.
Scott T WaltersUniversity of North Texas Health Science Center at Fort Worth, Fort Worth, TX, USA.
Faye S TaxmanGeorge Mason University, Schar School of Policy and Government, Fairfax, VA, USA.

Funding

HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance UptakeOT2OD034479 · OD · GEORGE MASON UNIVERSITY · PI TAXMAN, FAYE S · 2022 to 2023
$5.6M
NIH HHS OT2 OD034479
6 · The paper itself

Abstract

Background: To date, the NIH Helping to End Addiction Long-term (HEAL) Initiative has funded over 1,000 projects that aim to identify new therapeutic targets for pain and substance use disorder (SUD), develop nonpharmacological strategies for pain management, and improve overdose and addiction treatment across settings. This study conducted a portfolio analysis of HEAL's research to assess opportunities to advance translation and implementation. Methods: HEAL projects (FY 2018-2022) were classified into early (T0-T1) and later (T2-T4) translational stages. Eleven coders used a 54-item data collection tool based on the Consolidated Framework for Implementation Research (CFIR) to extract project characteristics (e.g., population, research setting) relevant to translation and implementation. Descriptive statistics and visualization techniques were employed to analyze and map aggregate characteristics onto CFIR's domains (e.g., outer setting). Results: HEAL's portfolio comprised 923 projects (33.7% T0-T1; 67.3% T2-T4), ranging from basic science (27.1%) and preclinical research (21.4%) to clinical (36.8%), implementation (27.1%), and dissemination research (13.1%). Most projects primarily addressed either addiction (46.3%) or pain (37.4%). Implementation-related gaps included the underrepresentation of certain populations (e.g., sexual/gender minorities: 0.5%). T0-T1 projects occurred primarily in laboratory settings (35.1%), while T2-T4 projects were concentrated in healthcare settings (e.g., hospitals: 21.6%) with limited transferability to other contexts (e.g., community: 12.9%). Conclusion: Opportunities to advance translational and implementation efforts include fostering interdisciplinary collaboration, prioritizing underserved populations, engaging with community leaders and policy stakeholders, and targeting evidence-based practices in nonclinical settings. Ongoing analyses can guide strategic investments to maximize HEAL's impact on substance use and pain crises.

Indexed as

addictionCFIRimplementation sciencepainTranslational science

Identifiers

PMID40395395
PMCPMC12089859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.